245 related articles for article (PubMed ID: 9806393)
21. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation.
Gil W
Perfusion; 2001 Jan; 16(1):27-35. PubMed ID: 11192304
[TBL] [Abstract][Full Text] [Related]
22. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
[TBL] [Abstract][Full Text] [Related]
23. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation management during pulmonary endarterectomy with cardiopulmonary bypass and deep hypothermic circulatory arrest.
Veerhoek D; van Barneveld LJ; Haumann RG; Kamminga SK; Vonk AB; Boer C; Symersky P
Perfusion; 2021 Jan; 36(1):87-96. PubMed ID: 32522088
[TBL] [Abstract][Full Text] [Related]
25. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass.
Bernabei A; Gikakis N; Maione TE; Kowalska MA; Yan Z; Niewiarowski S; Edmunds LH
J Thorac Cardiovasc Surg; 1995 Apr; 109(4):765-71. PubMed ID: 7715225
[TBL] [Abstract][Full Text] [Related]
26. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.
Ernofsson M; Thelin S; Siegbahn A
J Thorac Cardiovasc Surg; 1997 Mar; 113(3):576-84. PubMed ID: 9081105
[TBL] [Abstract][Full Text] [Related]
27. Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.
Benedict CR; Ryan J; Wolitzky B; Ramos R; Gerlach M; Tijburg P; Stern D
J Clin Invest; 1991 Nov; 88(5):1760-5. PubMed ID: 1939660
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
[TBL] [Abstract][Full Text] [Related]
29. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ; Ofosu FA; Buchanan MR
Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
[TBL] [Abstract][Full Text] [Related]
30. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
31. A potent anti-coagulant RNA aptamer inhibits blood coagulation by specifically blocking the extrinsic clotting pathway.
Gopinath SC; Shikamoto Y; Mizuno H; Kumar PK
Thromb Haemost; 2006 May; 95(5):767-71. PubMed ID: 16676065
[TBL] [Abstract][Full Text] [Related]
32. Factor IX from prothrombin complex concentrate augments low dose tissue factor-triggered thrombin generation in vitro.
Hasan S; Abuelkasem E; Williams B; Henderson R; Mazzeffi MA; Tanaka KA
Br J Anaesth; 2018 Oct; 121(4):936-943. PubMed ID: 30236256
[TBL] [Abstract][Full Text] [Related]
33. Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
Rao AK; Sun L; Hiramatsu Y; Gorman JH; Edmunds LH
Thromb Haemost; 1999 Jul; 82(1):140-4. PubMed ID: 10456468
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M
Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781
[TBL] [Abstract][Full Text] [Related]
35. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
Radulovic V; Laffin A; Hansson KM; Backlund E; Baghaei F; Jeppsson A
PLoS One; 2015; 10(7):e0130271. PubMed ID: 26134993
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone.
Lollar P; Fass DN
Arch Biochem Biophys; 1984 Sep; 233(2):438-46. PubMed ID: 6435527
[TBL] [Abstract][Full Text] [Related]
37. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
38. A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding.
Kremers RM; Bosch YP; Bloemen S; de Laat B; Weerwind PW; Mochtar B; Maessen JG; Wagenvoord RJ; Al Dieri R; Hemker HC
Thromb Haemost; 2016 Aug; 116(3):442-51. PubMed ID: 27121983
[TBL] [Abstract][Full Text] [Related]
39. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
[TBL] [Abstract][Full Text] [Related]
40. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
Teoh KH; Young E; Bradley CA; Hirsh J
Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
